FMD K&L is a global contract research organization supporting data management, biostatistics, statistical programming, clinical operations, regulatory affairs, safety, pharmacovigilance, toxicology, medical affairs, medical writing, quality, risk, and compliance services to the pharmaceutical, biotechnology, and medical device industries worldwide. We continuously strive to raise the standard of excellence through accuracy and efficiency to achieve the highest quality output for our partners. K&L was established in the US in 1995, and has grown to more than 1,400 employees worldwide, with key offices and delivery centers in the US, UK, China, India, Armenia, Japan and throughout the Asia-Pacific region.
Click above on Services to explore our broad capabilities and offerings.
A Top 5 consumer health company has pledged to meet all safety and environmental standards while maintaining the efficacy that their brand has historically delivered. Accomplishing this will require reformulation of more than 200 consumer products within 2 years, without affecting the brand image.
The Rx-to-OTC market in U.S. has grown into a $7.8 billion market. Are you ready to make the switch? This white paper discusses the Rx-to-OTC process, challenges, strategies and the roadmap for pharmaceutical companies to execute a successful switch.
Follow FMD K&L on LinkedIn for the latest on global product development. Read breaking stories, editorials by key opinion leaders, and articles by and/or about FMD K&L.